Pharma Buy-Side Advisory Services

Transjovan Capital helps pharma and life sciences companies pursue disciplined inorganic growth through strategic target screening, diligence support, valuation insight, negotiation guidance, and integration planning. From capability-led acquisitions to cross-border expansion, the team brings partner-led execution and deep corporate development experience to help buyers move with clarity, speed, and stronger post-deal value realization.

Pharma M&A advisory team reviewing acquisition strategy

Our Pharma Buy-Side Advisory Services

End-to-end support for pharma acquisitions, integration planning, and strategic corporate development initiatives.

Buy-Side M&A

Comprehensive support spanning acquisition strategy, target sourcing, outreach, valuation, diligence, negotiation support, transaction documentation assistance, and closing readiness for pharma and life sciences buyers.

Day-1 Readiness

Operational planning for the first day after closing, helping buyers align teams, priorities, governance, and execution so acquired businesses transition smoothly and momentum is preserved.

PMI & Synergy PMO

Post-merger integration and synergy governance support with workstream management, tracking dashboards, reporting, and alignment across culture, processes, and systems after acquisition.

Cross-border Buyout

Advisory for international acquisitions, combining cross-border transaction experience with strategic coordination across markets, stakeholders, and regulatory considerations relevant to global pharma expansion.

Strategic Programs

Ongoing corporate development support for multi-deal pipelines, portfolio reviews, and strategic evaluations that help acquisitive pharma companies build repeatable inorganic growth capabilities.

Board Advisory

Strategic guidance for boards and leadership teams on capital allocation, growth priorities, transaction rationale, and decision-making around acquisitions and broader corporate development agendas.

Partner-Led Execution

Built for Complex Pharma Acquisitions

Pharma buy-side transactions demand more than target lists and valuation models. Transjovan Capital supports buyers across strategy, sourcing, diligence, negotiation, Day-1 planning, and integration readiness, helping leadership teams evaluate assets with sharper commercial and operational context. With cross-border experience, senior-led execution, and a focus on synergy capture, the firm helps life sciences acquirers pursue deals that strengthen capabilities and create measurable post-close value.

Advisors planning a pharma acquisition strategy
The Transjovan Difference

Why Choose Transjovan Capital?

Senior-led advisory built for complex, high-stakes corporate development decisions.

Experienced Leaders

Partner-led teams include ex-Big-4 professionals, ex-CXOs, and seasoned M&A operators.

Global Reach

Cross-border execution support spans the US, Europe, India, and APAC for international dealmaking.

Proven Track Record

The firm has advised 250+ clients on cumulative transactions exceeding USD 15 billion.

Value Focus

Engagements emphasize synergy capture, integration readiness, and long-term strategic fit beyond closing.

Meet The Advisory Team

Experienced dealmakers and operators guiding complex transactions.

Gaurav Asthana Managing Partner headshot

Gaurav Asthana

Managing Partner

Gaurav Asthana is the Managing Partner at Transjovan Capital and brings more than 21 years of experience in mergers and acquisitions and private equity. An ex-Ernst & Young and KPMG professional, he is widely recognized for cross-border M&A execution across four continents. He has advised Fortune 500 corporations, large conglomerates, and private equity funds on cumulative transactions worth USD 15 billion. His experience includes retained buy-side mandates for globally recognized enterprises such as Blackstone, Mahindra, Legrand, Altana, Sumitomo, and Cummins. Under his leadership, the firm earned recognition as the Best M&A Advisory Firm in India. He also serves in prominent industry bodies including the Indo-American, Indo-French, and Indo-German Chambers of Commerce, reflecting his strong global business network.

Deoki Muchhal Head - Consumer headshot

Deoki Muchhal

Head - Consumer

Deoki Muchhal is a strategist and advisor with extensive leadership experience across large multinational organizations. Having served as MD and CFO at Cargill India, he has led acquisitions, divestitures, joint ventures, and technology transformation initiatives designed to unlock long-term enterprise value. His background includes board-level exposure, corporate restructuring, turnaround strategy, and successful merger integration. Deoki brings a practical operator's perspective to strategic advisory, helping clients align financial, operational, and transformation priorities. He also has a strong interest in ventures that improve competitiveness through digital technologies. A meritorious Chartered Accountant and alumnus of a Fortune 50 high-performance leadership academy, he adds seasoned financial and strategic judgment to complex growth and transaction mandates.

Rajesh Relan Head – Financial Services headshot

Rajesh Relan

Head – Financial Services

Rajesh Relan brings 37 years of experience, including 25 years in senior leadership roles across the insurance industry in India and the Asia Pacific region. He previously served as Managing Director of PNB MetLife India Insurance and has deep expertise in strategy, governance, financial planning, business transformation, and M&A. His career includes launching and scaling businesses, leading turnarounds, and executing acquisitions, including the purchase of an insurance broking company. Rajesh also serves as an independent director on boards of publicly listed companies, including Singer India Ltd. and Jaykay Enterprises. His involvement with industry bodies such as CII, FICCI, Amcham, and USIBC reflects broad market engagement. He contributes seasoned boardroom insight to strategic growth and transaction advisory assignments.

Anuraag Guptaa Head – IT Services headshot

Anuraag Guptaa

Head – IT Services

Anuraag Guptaa has 27 years of experience in IT services spanning BFSI, consulting, professional services, and BPO. He has held CEO and board-level roles at organizations including First Meridian, Quess Corp, Capgemini, and Gulf Bank. At Quess Corp, he helped build India's largest technology staffing firm, culminating in a 2016 IPO at a valuation of USD 2 billion. His strengths include operational transformation, P&L leadership, greenfield venture incubation, organizational restructuring, and navigating complex M&A environments. Anuraag also mentors and invests in niche startups, bringing a growth-oriented perspective to advisory work. He is an alumnus of Harvard Business School and holds an MBA from LSE, NYU Stern, and HEC Paris, along with Six Sigma Master Black Belt certification from GE.

Chetan Tolia Senior Advisor headshot

Chetan Tolia

Senior Advisor

Chetan Tolia brings more than 30 years of leadership experience across major industrial organizations. He has served as a director on the boards of 10 Tata companies and was CEO and Executive Director of WREPL, a Tata Power company in the renewables business. His background also includes serving as Chief HR Officer of Tata Power, CEO of Tata BlueScope Steel Limited, and head of Strategy & Planning at Tata Steel. He played a key role in forming the BlueScope Steel and Tata Steel joint venture and in shaping growth strategy for large industrial businesses. With deep exposure to strategy, joint ventures, board governance, and industrial operations, Chetan adds valuable manufacturing and infrastructure insight to enterprise advisory engagements.

Portrait of Atishay Jain

Atishay Jain

Portrait of Ananya Ranka

Ananya Ranka

Portrait of Avya Malik

Avya Malik

Portrait of Chetan Tolia

Chetan Tolia

Senior Advisor

Portrait of Shanti Priya

Shanti Priya

Frequently Asked Questions

What does a buy-side advisor do?

A buy-side advisor helps an acquirer identify, evaluate, and execute acquisitions. That typically includes acquisition strategy, market mapping, target sourcing, outreach, valuation support, diligence coordination, negotiation assistance, and closing readiness. In more complex mandates, the advisor also supports Day-1 planning, post-merger integration, and synergy tracking so the buyer can focus on strategic decisions while maintaining execution discipline.

What is life science advisory?

What are considered life sciences?

How do pharma buy-side advisory services support acquisition strategy?

When should a pharma company engage a buy-side advisor?

Do buy-side advisors help with cross-border pharma acquisitions?

What is included in end-to-end buy-side M&A support?

How is success measured in a pharma acquisition advisory engagement?

Still Evaluating a Pharma Deal?

Speak with senior advisors about strategy, targets, diligence, and integration planning.

Trusted Credentials

Awards and Recognition

Best M&A Advisory Firm award logo

Best M&A Advisory Firm

Recognized in India for 2024 excellence.

TiE Global membership logo

TiE Global Member

Connected to global entrepreneurial networks.

International chamber memberships logo

Chamber Network Memberships

Active across major international business chambers.

Start the Right Acquisition Conversation

Share your strategic priorities, target themes, or active deal requirements, and our team will outline how we can support your buy-side process.

Contact Us Today

For immediate assistance, feel free to give us a direct call at 1800 102 5700. You can also send us a quick email at info@transjovancap.com.